700 QUINCE ORCHARD ROAD, GAITHERSBURG, MD
Market cap: $1.4B (2/08/2026)
Price: $8.70
License Agreement with Pfizer for Matrix-M Technology
Investor Presentation
Reports Third Quarter 2025 Financial Results and Operational Highlights
Completes U.S. Marketing Authorization Transfer for Nuvaxovid™, Triggering a $25 Million Milestone Payment
Novavax, Inc. Enters Material Agreement with AstraZeneca for Facility Lease
Continues to Deliver on Partnership, Completing Nuvaxovid® EU Marketing Authorization Transfer and Triggering $25 Million Milestone Payment
News, Securities Holder Rights or Indentures
Nuvaxovid™ 2025-2026 Formula COVID-19 Vaccine Approved in the U.S.
Q3
Q2
Q1
FY 2023
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
S-3ASR
Additional Proxy Materials
Definitive Proxy Statement
Definitive Additional Information Statement
Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Amended Schedule 13D - Ownership Report
Definitive Revised Proxy Statement
Free Writing Prospectus
Prospectus filed pursuant to Rule 424(b)(7)
Correspondence
Submission Upload
Confidential Treatment Order